Literature DB >> 12533339

Idiopathic hypertrophic cranial pachymeningitis: case report with 7 years of imaging follow-up.

Yu Chang Lee1, Yao Chung Chueng, Shin Wei Hsu, Chun Chung Lui.   

Abstract

Idiopathic hypertrophic cranial pachymeningitis is a rare inflammatory disease with diffused involvement of the dura. Often, the definite diagnosis is made immediately with biopsy and the involved dura is removed surgically. Consequently, extensive preoperative imaging studies usually are not available. We reviewed a case of idiopathic hypertrophic cranial pachymeningitis and collectively summarized the interesting features from the 7 years preceding surgical treatment. These chronologic imaging findings with progressive intracranial involvement included dural thickening, dural mass, sinus thrombosis, and venous congestion constituted comprehensive pictures of idiopathic hypertrophic cranial pachymeningitis. The thickened dura may also at times mimic dural masses, such as en plaque meningioma.

Entities:  

Mesh:

Year:  2003        PMID: 12533339      PMCID: PMC8148956     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  10 in total

1.  Idiopathic hypertrophic cranial pachymeningitis: clinicoradiological spectrum and therapeutic options.

Authors:  N Hatano; S Behari; T Nagatani; M Kimura; K Ooka; K Saito; J Yoshida
Journal:  Neurosurgery       Date:  1999-12       Impact factor: 4.654

2.  Optic neuropathy associated with hypertrophic cranial pachymeningitis.

Authors:  T Harada; T Ohashi; K Ohki; H Kato; M Takamura; K Yoshida; H Matsuda; Y Sawamura; T Itoh
Journal:  Br J Ophthalmol       Date:  1996-06       Impact factor: 4.638

3.  [Intracranial granulomatous pachymeningitis with pseudotumoral symptomatology. Apropos of 4 cases].

Authors:  D Michel; P F Girard; M Tommasi; R Masson; M Trillet; J P Piccinali
Journal:  J Med Lyon       Date:  1969-04-05

4.  Contrast-enhanced MR imaging of idiopathic hypertrophic craniospinal pachymeningitis.

Authors:  D Friedman; A Flanders; L Tartaglino
Journal:  AJR Am J Roentgenol       Date:  1993-04       Impact factor: 3.959

5.  Hypertrophic cranial pachymeningitis: assessment with CT and MR imaging.

Authors:  N Martin; C Masson; D Henin; D Mompoint; C Marsault; H Nahum
Journal:  AJNR Am J Neuroradiol       Date:  1989 May-Jun       Impact factor: 3.825

6.  Hypertrophic granulomatous cranial pachymeningitis causing progressive blindness in a chronic dialysis patient.

Authors:  E R Feringa; L Weatherbee
Journal:  J Neurol Neurosurg Psychiatry       Date:  1975-12       Impact factor: 10.154

7.  Idiopathic hypertrophic pachymeningitis: spectrum of the disease.

Authors:  M Goyal; A Malik; N K Mishra; S B Gaikwad
Journal:  Neuroradiology       Date:  1997-09       Impact factor: 2.804

8.  -A successful case of hypertrophic cranial pachymeningitis treated by optic nerve decompression.

Authors:  T Horiguchi; K Gotoh; K Yoshida; S Toya
Journal:  No Shinkei Geka       Date:  1996-03

Review 9.  Idiopathic hypertrophic cranial pachymeningitis. Report of three cases.

Authors:  A N Mamelak; W M Kelly; R L Davis; M L Rosenblum
Journal:  J Neurosurg       Date:  1993-08       Impact factor: 5.115

10.  Multifocal fibrosclerosis with hypertrophic intracranial pachymeningitis.

Authors:  J R Berger; S Snodgrass; J Glaser; M J Post; M Norenberg; P Benedetto
Journal:  Neurology       Date:  1989-10       Impact factor: 9.910

  10 in total
  18 in total

1.  Rapidly progressive fatal idiopathic hypertrophic pachymeningitis with brainstem involvement in a child.

Authors:  Kosuke Tsuchida; Shinobu Fukumura; Akiyo Yamamoto; Yukinori Akiyama; Hiroshi Hirano; Hiroyuki Tsutsumi
Journal:  Childs Nerv Syst       Date:  2018-05-05       Impact factor: 1.475

2.  Letter to the editor: citations for the case report on idiopathic hypertrophic pachymeningitis by Kosuke Tsuchida et al.

Authors:  Shi-Jun Li
Journal:  Childs Nerv Syst       Date:  2019-01-23       Impact factor: 1.475

Review 3.  [Hypertrophic cranial pachymeningitis as a rare cause of headache].

Authors:  J Kuhn; A Harzheim; S Riku; W Müller; H Bewermeyer
Journal:  Nervenarzt       Date:  2006-04       Impact factor: 1.214

Review 4.  Idiopathic hypertrophic pachymeningitis: an autoimmune IgG4-related disease.

Authors:  Armando De Virgilio; Marco de Vincentiis; Maurizio Inghilleri; Giovanni Fabrini; Michela Conte; Andrea Gallo; Maria Ida Rizzo; Antonio Greco
Journal:  Immunol Res       Date:  2017-02       Impact factor: 2.829

5.  Idiopathic hypertrophic cranial pachymeningitis misdiagnosed as acute subtentorial hematoma.

Authors:  Ik-Seong Park; Hoon Kim; Eun Yong Chung; Kwang Wook Cho
Journal:  J Korean Neurosurg Soc       Date:  2010-08-31

6.  Idiopathic hypertrophic spinal pachymeningitis: report of two cases with typical MR imaging findings.

Authors:  S Pai; C T Welsh; S Patel; Z Rumboldt
Journal:  AJNR Am J Neuroradiol       Date:  2007-03       Impact factor: 3.825

7.  Effective Response of Methotrexate for Recurrent Idiopathic Hypertrophic Spinal Pachymeningitis.

Authors:  Tae Joon Park; Won Deok Seo; Sang Young Kim; Jae Hoon Cho; Dae Hyun Kim; Ki Hong Kim
Journal:  Korean J Spine       Date:  2016-12-31

8.  Long-term outcome of idiopathic hypertrophic thoracic pachymeningitis.

Authors:  Mio Tsutsui; Taketoshi Yasuda; Masahiko Kanamori; Takeshi Hori; Tomoatsu Kimura
Journal:  Eur Spine J       Date:  2011-05-19       Impact factor: 3.134

9.  Prevalence of and Factors Associated with Dural Thickness in Patients with Mild Cognitive Impairment and Alzheimer's Disease.

Authors:  Adnan I Qureshi; Iryna Lobanova; Naseeb Ullah; Amna Sohail; Taqi A Zafar; Adil M Malik; Mushtaq H Qureshi
Journal:  J Vasc Interv Neurol       Date:  2015-07

10.  Commentary.

Authors:  Max R Lowden
Journal:  J Neurosci Rural Pract       Date:  2012-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.